Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of MSLN mRNA | increases expression | 20713471
|
C029955 |
2-nitrotoluene |
2-nitrotoluene results in increased expression of MSLN mRNA | increases expression | 16460773
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MSLN mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of MSLN mRNA | increases expression | 20713471
|
C099813 |
bromochloroacetic acid |
bromochloroacetic acid results in increased expression of MSLN mRNA | increases expression | 16460773
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MSLN mRNA | decreases expression | 15336504
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of MSLN mRNA | decreases expression | 17557909
|
D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in decreased expression of MSLN mRNA | decreases expression | 16823509
|
D008727 |
Methotrexate |
MSLN protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of MSLN mRNA | increases expression | 20713471
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of MSLN mRNA | increases expression | 17616710
|
D043371 |
Fatty Acids, Omega-6 |
Fatty Acids, Omega-6 results in increased expression of MSLN mRNA | increases expression | 16823509
|
D010126 |
Ozone |
Ozone results in increased expression of MSLN mRNA | increases expression | 12763052
|
D011374 |
Progesterone |
Progesterone results in increased expression of MSLN mRNA | increases expression | 17404688
|
D013755 |
Tetradecanoylphorbol Acetate |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MSLN mRNA | affects cotreatment|affects expression | 16979875
|
D015032 |
Zinc |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MSLN mRNA | affects cotreatment|affects expression | 16979875
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.27 | 12039119 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.42 | 17202136 17190629 16889938 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.18 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.18 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.87 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
6.87 | 6695378 10545420 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.46 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.46 | 16580781 16325427 16410023 17119284 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.91 | 16916123 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.98 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.98 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
5.18 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Zinc |
5.18 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.45 | 11922910 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
9.27 | 18448859 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-6 |
9.27 | 18448859 |
MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
3.48 | 16920077 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
11.09 | 15665606 15380490 15845082 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
11.09 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.38 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.38 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.38 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.38 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.38 | 17614352 15562024 16175315 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.68 | 17626835 18417511 14754758 15516495 19059883 18315731 16777450 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.76 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
3.97 | 10545420 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.68 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.68 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
7.68 | 16543248 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.66 | 16936243 |
MESH:D002430 |
Cecal Neoplasms |
|
2-nitrotoluene |
5.68 | 14688030 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
3.50 | 16192471 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.88 | 15861022 16105132 17110522 17681005 17333356 16919318 11677210 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.19 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
3.19 | 19302082 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.24 | 19747007 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.13 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.21 | 16479319 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
3.62 | 8273558 9599246 15177302 7812673 16716910 8113982 11698051 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.07 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.07 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.77 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.39 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
7.39 | 15878914 15547721 15547733 16704527 16805852 15623463 16510608 15150132 15264214 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
7.39 | 16543248 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
2.82 | 15345470 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.96 | 14633661 10962813 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.83 | 17241300 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.16 | 16518429 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.96 | 17217573 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.66 | 20471113 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.61 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.80 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.54 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
|
2-nitrotoluene |
5.08 | 13678655 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.70 | 17276780 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.49 | 17937319 |
MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
8.69 | 17296493 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.69 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
8.69 | 8273558 15177302 7562506 7812673 11698051 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.64 | 16584753 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
3.32 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.42 | 16518626 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.11 | 9562676 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.70 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.04 | 20195826 21137059 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
3.28 | 1399818 598648 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.38 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.05 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.86 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.93 | 20464547 20064080 20135361 20869020 18816296 17053015 6695378 18520028 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
4.93 | 6695378 7750092 11893704 20970405 20512841 1399818 21163286 16337739 17909032 16271038 15390079 10545420 9230183 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
4.93 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
4.93 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.95 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
14.40 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
14.40 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
14.40 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
14.40 | 12773700 |
MESH:D008654 |
Mesothelioma |
marker/mechanism |
|
| 18394747 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.14 | 10496685 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.19 | 16381670 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.30 | 17488658 |
MESH:D019042 |
Muscle Neoplasms |
|
2-nitrotoluene |
6.71 | 13678655 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.17 | 11141357 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.52 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.13 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.31 | 18404319 18922899 8330346 12065085 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.14 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.41 | 18929643 18381685 18007984 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.18 | 17114810 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.38 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.38 | 16606632 16517595 12429649 16700911 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.43 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.72 | 17352296 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.13 | 16584753 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.57 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.57 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.57 | 18404319 12065085 8330346 11807781 8985016 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.97 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.30 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.54 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.54 | 12958204 17575124 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.04 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.40 | 16543248 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.18 | 17053015 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |